DMT1 (NRAMP2/DCT1) genetic variability and resistance to rhEpo therapy in chronic kidney disease patients under hemodialysis

• Tipo: Resumo de Comunicação em Conferência Internacional
• Data: 2008

Autores

Elísio Costa (Autor) Outra; Susana Rocha (Autor) FFUP; Petronila Rocha -Pereira (Autor) Outra; Flávio Reis (Autor) Outra; Eleisabeth Castro (Autor) FFUP; Frederico Teixeira (Autor) Outra; Vasco Miranda (Autor) Outra; Maria do sameiro-Faria (Autor) Outra; Alfredo Loureiro (Autor) Outra; Alexandre Quintanilha (Autor) Outra; Luís Belo (Autor) FFUP; Alice santos-Silva (Autor) FFUP

Ata de Conferência Internacional

Título: Portuguese Journal of Nephrology and Hypertension

Páginas: ii154-ii154

23rd Congress of the Portuguese Society of Nephrology

Indexação

Pubmed / Medline

Classificação Científica

FOS: Ciências médicas e da saúde > Outras ciências médicas

CORDIS: Ciências da Saúde

Outras Informações

Resumo (PT): our study failed to demonstrate a link between mutations/polymorphisms in DMT1 gene, and resistance to rhEPO therapy. Moreover, no influence of DMT1 gene mutations/polymorphisms in rhEPO doses, haematological data and iron status was demonstrated in our CKD patients. <br> <br> <a target="_blank" href="http://ndtplus.oxfordjournals.org/cgi/reprint/1/suppl_2/ii26"> Texto integral</a> <br> <br>

Abstract (EN): our study failed to demonstrate a link between mutations/polymorphisms in DMT1 gene, and resistance to rhEPO therapy. Moreover, no influence of DMT1 gene mutations/polymorphisms in rhEPO doses, haematological data and iron status was demonstrated in our CKD patients. <br> <br> <a target="_blank" href="http://ndtplus.oxfordjournals.org/cgi/reprint/1/suppl_2/ii26">Full text </a> <br> <br>

Idioma: Português

Tipo (Avaliação Docente): Científica